- AI
- Molecular Imaging
- CT
- X-Ray
- Ultrasound
- MRI
- Facility Management
- Mammography
Video Blog: Siemens exec wrestles with 'meaningful use'
The Federal government is pushing medical practitioners toward the use of integrated electronic information systems. The hope is that these systems will improve the efficiency of medical care and reduce errors, thereby cutting costs and improving healthcare.
The Federal government is pushing medical practitioners toward the use of integrated electronic information systems. The hope is that these systems will improve the efficiency of medical care and reduce errors, thereby cutting costs and improving healthcare. The promise of reimbursement for the use of these systems is the incentive for care providers to adopt them. But semantics could get in the way. The need for “certified” systems that demonstrate “meaningful use” is a key requisite for reimbursement. But, as Janet Dillione, president of Health Services in the Healthcare IT division of Siemens Medical Solutions, noted at HIMSS2009, nobody is exactly sure how systems will be certified or what will constitute “meaningful use”. Where and how medical imaging IT, such as radiology information systems, will fit is anybody’s guess.
Four Strategies to Address the Tipping Point in Radiology
January 17th 2025In order to flip the script on the impact of the radiology workforce shortage, radiology groups and practices need to make sound investments in technologies and leverage partnerships to mitigate gaps in coverage and maximize workflow efficiencies.
Can Generative AI Facilitate Simulated Contrast Enhancement for Prostate MRI?
January 14th 2025Deep learning synthesis of contrast-enhanced MRI from non-contrast prostate MRI sequences provided an average multiscale structural similarity index of 70 percent with actual contrast-enhanced prostate MRI in external validation testing from newly published research.
Can MRI-Based AI Enhance Risk Stratification in Prostate Cancer?
January 13th 2025Employing baseline MRI and clinical data, an emerging deep learning model was 32 percent more likely to predict the progression of low-risk prostate cancer (PCa) to clinically significant prostate cancer (csPCa), according to new research.
